METTL17 and colorectal carcinoma: Collectively, these results highlight that METTL17 is overexpressed in human CRC, and its knockdown inhibits proliferation, migration, invasion, colony formation and cell cycle transition of CRC cells, at least in part, through disrupting the oncogenic pathway.